Back to Search Start Over

Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results

Subjects

Subjects :
Ophthalmology

Details

ISSN :
01616420
Database :
OpenAIRE
Journal :
Ophthalmology
Accession number :
edsair.doi...........76f4f1da178d51dfa7dd887f1cc2752f